BANC - Standing Committee

Banking, Commerce and the Economy

Past Session: Past Session:
37-1 37th Parliament, 1st Session (January 29, 2001 - September 16, 2002)
Select a different session

Meeting Detail
Televised live on PTN
Wednesday, March 21, 2001
When the Senate rises but not before 3:45 p.m. ET
Location: Room 505, Victoria Building
Clerk: Denis Robert (613) 993-4874
Bill S-17, An Act to amend the Patent Act
Witnesses
  • Dr. Aldo Baumgartner, President and Chief, Wyeth-Ayerst Canada Inc. Branch and President of the Executive Committee of Rx&D (As an Individual)
  • Susan Bincoletto, Chief Financial Officer (Industry Canada)
  • Bernadette Connaughton, President & General Manager (of Bristol-Myers Squibb Pharmaceutical Group)
  • Murray J. Elston, President of Rx&D (From Canada's Research-Based Pharmaceutical Companies:)
  • Terry McCool, Vice President of Corporate Affairs (of Eli Lilly Canada Inc.)
  • Mr. Andrei Sulzenko, Assistant Deputy Minister, Industry and Science Policy (Industry Canada)
  • Rob Sutherland-Brown, Senior Counsel (Industry Canada)
  • The Honourable Brian Tobin, P.C., M.P., Minister, Industry Canada (As an Individual)
  • Dan Wayand, General Manager (of Procter & Gamble Pharmaceuticals Canada Inc)
Bill S-16, An Act to amend the Proceeds of Crime (Money Laundering) Act

Clause-by-clause consideration

Meeting with interpretation and transcription